IRCT20200105046010N92招募中Unknown
Bioequivalence study of Fingolimod 0.5 mg capsule manufactured by Abidi Co (Norabex) versus originator brand Gilenya capsule manufactured by Novartis Co in fasting condition in healthy volunteers
Abidi Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Fingolimod
研究者
相似试验
招募中
Unknown
Bioequivalence study of Fingolimod capsule 0.5 mgIRCT20200623047902N34Alborz Zagros company24
尚未招募
不适用
Study of absorption and elimination rate of Fingolimod 0.5-mg capsule in comparison with Fingolimod brand Capsule (Gilenya®).Bioequivalence study.IRCT20200407046981N26Zahravi pharmaceutical company24
已完成
1 期
Bioequivalence Study of a Test Capsule Formulation of Fingolimod With the Reference Capsule Formulation of FingolimodHealthy VolunteersNCT03757338Asofarma S.A.I. y C.33
已完成
不适用
comparison of Fingolimode and Betaferon(high dose) in M.S treatmentMultiple SclerosisIRCT2015112025146N1Isfahan University of Medical Sciences50
尚未招募
1 期
A Bioequivalence Study of Two Formulations of 5 mg Montelukast Chewable Tablets in Healthy Thai Volunteers under Fasting ConditionsHealthy Thai VolunteersTCTR20210720012Siriraj Institute of Clinical Research (SICRES)28